Computed Tomography (CT) in Head and Neck Patients

Lung Tumors Clinical Trial

Official title:

Minimum Dose CT in the Detection of Lung Nodules in Patients With Head and Neck Cancer

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00188656
• Other study ID #: 03-0467
• Status: Terminated
• Phase: Phase 1
• First received: September 12, 2005
• Last updated: December 14, 2010
• Start date: August 2003
• Est. completion date: September 2006

Study information

• Verified date: December 2010
• Source: University Health Network, Toronto
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

This study is conducting a comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT) in the detection of lung nodules (metastases) in patients with head and neck carcinoma.

Description:

A comparison of chest x-ray (CXR) and minimum dose thoracic CT (MnDCT)in the detection of lung nodules (metastases) in patients with head and neck carcinoma

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 100
• Est. completion date: September 2006
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Patients with squamous cell carcinoma of the head and neck

Exclusion Criteria:

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Lung Tumors

Intervention

Procedure:
• CT thorax

Locations

Country	Name	City	State
Canada	Princess Margaret Hospital	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detection of lung metastases